Camas

Camas Biotherapeutics is a biotechnology company specializing in cell-free protein synthesis (CFPS) to revolutionize the manufacturing of biologics and vaccines. By decoupling protein production from living cells, the company's platform enables rapid, scalable, and cost-effective synthesis of complex therapeutic proteins. Camas focuses on addressing global health challenges by developing high-yield production methods for vaccines and essential medicines, particularly for low- and middle-income countries. Their technology aims to bypass the traditional bottlenecks of cell-based fermentation, offering a more flexible and robust alternative for biomanufacturing. The company leverages advanced synthetic biology to optimize biochemical pathways for maximum protein expression.